İLHAN, O. Et Al. 2020. A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib. 46th Annual Meeting of the European Society for Blood and Marrow Transplantation .

İLHAN, O., CENGİZ SEVAL, G., CİVRİZ BOZDAĞ, S., DEVECİ, B., PEHLİVAN, M., KAYNAR, L., ... YAVAŞOĞLU, İ.(2020). A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib . 46th Annual Meeting of the European Society for Blood and Marrow Transplantation

İLHAN, OSMAN Et Al. "A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib," 46th Annual Meeting of the European Society for Blood and Marrow Transplantation, 2020

İLHAN, OSMAN Et Al. "A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib." 46th Annual Meeting of the European Society for Blood and Marrow Transplantation , 2020

İLHAN, O. Et Al. (2020) . "A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib." 46th Annual Meeting of the European Society for Blood and Marrow Transplantation .

@conferencepaper{conferencepaper, author={OSMAN İLHAN Et Al. }, title={A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib}, congress name={46th Annual Meeting of the European Society for Blood and Marrow Transplantation}, city={}, country={}, year={2020}}